Cell Counting Kit-8 (CCK-8): Precision WST-8 Cell Viability Assay

Executive Summary: The Cell Counting Kit-8 (CCK-8) utilizes the water-soluble tetrazolium salt WST-8 for rapid, colorimetric quantification of viable cells, enabling high-throughput, non-radioactive assessment of cell proliferation and cytotoxicity (Zhang et al., 2025). Each assay produces a water-soluble formazan dye in direct proportion to mitochondrial dehydrogenase activity, allowing precise measurement by microplate reader. CCK-8 consistently outperforms MTT and XTT in sensitivity and workflow simplicity (see extended discussion). APExBIO's K1018 kit is widely validated for cancer biology, neurodegenerative disease modeling, and regenerative medicine applications (product page). Recent peer-reviewed studies confirm CCK-8's critical role in optimizing experimental workflows and interpreting cell health in vitro (DOI).

Biological Rationale

Cell Counting Kit-8 (CCK-8) addresses the fundamental need for quantitative, reproducible assessment of cell viability, proliferation, and cytotoxicity in vitro. Viable cells maintain mitochondrial metabolic activity, which is a key indicator of cellular health and function (Zhang et al., 2025). Traditional assays such as MTT and XTT require solubilization steps or generate insoluble formazan, complicating analysis. CCK-8, in contrast, uses WST-8, a water-soluble tetrazolium salt, enabling direct measurement of viable cells through enzymatic reduction by cellular dehydrogenases. This allows researchers to track proliferation kinetics, evaluate cytotoxic compounds, and assess metabolic modulation in disease and drug screening models. The approach is suitable for a wide range of cell types, including primary cells, stem cells, and immortalized lines, supporting studies in oncology, neurodegeneration, and tissue engineering.

Mechanism of Action of Cell Counting Kit-8 (CCK-8)

CCK-8's functional core is the WST-8 reagent, a water-soluble tetrazolium salt. Live cells with intact mitochondrial function enzymatically reduce WST-8 via intracellular dehydrogenases, producing a soluble formazan dye. The amount of formazan generated is directly proportional to the number of metabolically active cells. The reaction is performed in aqueous buffer, typically at 37°C and neutral pH, and does not require organic solvents or additional solubilization steps. Absorbance is measured at 450 nm using a microplate reader. Because the dye is water-soluble, multiple time-point measurements are possible, and the workflow is compatible with automation and high-throughput screening.

Evidence & Benchmarks

• CCK-8 assay enables accurate quantification of human dental pulp stem cell (hDPSC) proliferation and was used to determine optimal concentrations of test compounds (Zhang et al., 2025, DOI).
• WST-8-based CCK-8 exhibits higher sensitivity and linearity compared to MTT and XTT, especially at low cell densities (site article).
• Formazan produced by CCK-8 is fully water-soluble, eliminating the need for post-assay solubilization and simplifying workflow (APExBIO).
• CCK-8 is validated for multiple cell types, including cancer, neural, and fibroblast models, across diverse disease research applications (site article).
• The K1018 kit from APExBIO shows high reproducibility and low background in high-throughput cytotoxicity assays (product data).

This article extends previous insights on WST-8-based cell viability measurement by providing direct clinical benchmarking with recent peer-reviewed research and a detailed workflow analysis. For more on translational research applications, see strategic utility in hepatocellular carcinoma studies. For fibroblast phenotyping and osteoarthritis models, review unique fibroblast applications.

Applications, Limits & Misconceptions

CCK-8 is widely used for:

• Quantitative cell proliferation assays in cancer research, neurodegenerative disease modeling, and primary cell studies.
• Cytotoxicity screening for drug candidates, environmental toxins, and gene editing outcomes.
• Metabolic activity assessment in mitochondrial function studies and apoptosis/necrosis distinction.

Its sensitivity makes it suitable for low cell numbers and rare cell populations. However, the assay specifically measures mitochondrial dehydrogenase activity, which may not fully represent cell viability under certain metabolic or apoptotic conditions (Zhang et al., 2025).

Common Pitfalls or Misconceptions

• CCK-8 does not distinguish between different cell death mechanisms (apoptosis vs. necrosis); it only reports metabolic activity.
• Highly reducing compounds or culture supplements may interfere with WST-8 reduction, causing false positives.
• Assay results are influenced by cell type, metabolic state, and density; calibration curves are essential for each experimental system.
• The kit is not suitable for non-adherent cells unless optimized for plate-based sedimentation.
• Prolonged incubation (>4 hours) may increase background due to non-specific reduction or medium instability.

Workflow Integration & Parameters

To use the Cell Counting Kit-8 (CCK-8), cells are seeded into 96-well plates at densities from 1 × 10³ to 1 × 10⁵ cells/well, depending on cell type and proliferation rate. After experimental treatments, 10 µL of CCK-8 reagent is added to 100 µL of medium per well. The plate is incubated at 37°C in a humidified CO₂ incubator for 1–4 hours. Absorbance is measured at 450 nm. The signal is stable for at least 1 hour post-incubation. For drug screening, viability is reported as a percentage of untreated controls. The K1018 kit supports up to 5,000 assays per package, enabling large-scale screens (product documentation).

Conclusion & Outlook

APExBIO's Cell Counting Kit-8 (CCK-8) delivers sensitive, reproducible, and scalable measurement of cell viability and proliferation, with broad validation across disease models and primary cell lines. Its water-soluble, WST-8-based design offers workflow simplicity over legacy MTT/XTT methods and is validated in peer-reviewed studies for both fundamental and translational research (Zhang et al., 2025). As cellular metabolism and drug discovery platforms evolve, CCK-8's compatibility with automation and high-throughput screening ensures its continued relevance. For researchers seeking robust, quantitative, and low-background viability assessment, the K1018 kit represents a benchmark solution (order information).